https://www.biopharminternational.com/view/precautionary-measures-recommended-in-use-of-valproate-medicines
0
0
1/15/24 at 8:07pm
Organization
Biopharminternational.com
Author
Susan Haigney
33 words
0
Comments
The European Medicines Agency safety committee says there is a potential risk of neurodevelopment disorders in children born to men treated with valproate.
You are the first to view
Create an account
or login to join the discussion